A Kasprzak, W Kwasniewski, A Adamek… - … Research/Reviews in …, 2017 - Elsevier
Determination of the role of insulin-like growth factor (IGF) family components in carcinogenesis of several human tumors is based on numerous epidemiological and pre …
Y Tantamango-Bartley, K Jaceldo-Siegl, J Fan… - … , biomarkers & prevention, 2013 - AACR
Background: Cancer is the second leading cause of death in the United States. Dietary factors account for at least 30% of all cancers in Western countries. As people do not …
YF Chen, WT Chiu, YT Chen, PY Lin… - Proceedings of the …, 2011 - National Acad Sciences
Store-operated Ca2+ entry (SOCE) is the principal Ca2+ entry mechanism in nonexcitable cells. Stromal-interaction molecule 1 (STIM1) is an endoplasmic reticulum Ca2+ sensor that …
MY Lee, CY Chou, MJ Tang, MR Shen - Clinical Cancer Research, 2008 - AACR
Purpose: Acquisition of epithelial-mesenchymal transition (EMT) by primary carcinoma cells is associated with disrupted epithelial integrity, local invasion, and ultimately metastasis …
S Barr, S Thomson, E Buck, S Russo, F Petti… - Clinical & experimental …, 2008 - Springer
Over 90% of all cancers are carcinomas, malignancies derived from cells of epithelial origin. As carcinomas progress, these tumors may lose epithelial morphology and acquire …
M Luo, D Shen, X Zhou, X Chen, W Wang - Surgery, 2013 - Elsevier
BACKGROUND: Increasing evidence has shown that microRNAs function as oncogenes or tumor suppressors in human malignancies, but the roles of microRNA (miR)-497 in human …
S Loeper, S Ezzat - Reviews in Endocrine and Metabolic Disorders, 2008 - Springer
Acromegaly is characterized by sustained elevation of circulating growth hormone (GH) and insulin-like growth factor I (IGF-I), and is clearly associated with increased morbidity and …
Exogenous application of an electric field can direct cell migration and improve wound healing; however clinical application of the therapy remains elusive due to lack of a suitable …
L Wang, Y Liu, Y Zhou, J Wang, L Tu, Z Sun… - Journal of Experimental …, 2019 - Springer
Background Zoledronic acid is the most potent osteoclast inhibitor and is widely used for advanced cancer patients with bone metastasis, but its role on cancer stem cells (CSCs) …